ORMP Oramed Pharmaceuticals Inc.
$4.16▲ +1.96%
Healthcare
Other
After hours
$4.16▲ +0.00%
Oct 27, 4:01 PM ET
Volume 97.2K
Avg Volume (10D) 137.8K
Key Metrics & Fundamentals
Market Cap
$173.04M
P/E Ratio
1.0
Div Yield
6.14%
52W Range
2.09 - 5.47
% vs 50 MA
-9.69%
% vs 200 MA
3.43%
RSI-14
40.3
MACD Histogram
+0.0000
Beta (1Y vs SPY)
1.17
Free Cash Flow
-$202,000
Gross Rev
$0
Gross Profit
$0
EBITDA
-$2.74M
COGS
$0
Operating Exp
$2.77M
Operating Income
-$2.77M
EBIT
-$2.77M
Pretax Income
$101.59M
Net Income
$78.16M
EPS (Diluted)
1.84
Price & Volume History
Loading chart…
Recent News
Lifeward Publishes Updated Investor Presentation Highlighting Commercial Growth Strategy
GlobeNewswire · Sep 8, 2026 8:30 AM ET
Lifeward Names Josh Hexter as Interim CEO and Rami Aviram as CFO
MT Newswires · Aug 31, 2026 4:44 PM ET
ORMP: Investment Gains Contributed to Strong 2Q26 EPS, While Inclusion in Russell Indexes Arguably Boosts Awareness
Zacks Small Cap Research · Aug 28, 2026 5:30 AM ET
Nano Dimension Appoints Nadav Kidron to Board of Directors to Chair Strategy and Capital Allocation Committee
GlobeNewswire · Aug 17, 2026 8:00 AM ET
Oramed: Q2 Earnings Snapshot
Associated Press · Aug 10, 2026 5:39 PM ET
Financial Overview - Income Statement
Quarterly
Mar 2025
See ORMP's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.